临床肿瘤学
医学
癌症
内科学
肿瘤科
医学物理学
作者
Feng Hua Wang,Lin Shen,Jin Li,Zhi Wei Zhou,Han Liang,Xiao Tian Zhang,Lei Tang,Yan Xin,Jing Jin,Yu Jing Zhang,Xianglin Yuan,Tian Shu Liu,Guo Xin Li,Qi Wu,Hui Xu,Jiafu Ji,Yuan Fang Li,Xin Wang,Shan Yu,Hao Liu,Wen Long Guan,Rui Xu
标识
DOI:10.1186/s40880-019-0349-9
摘要
Abstract China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non‐Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence‐based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow‐up visits for gastric cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI